← SkinHealth Systems Inc. SKIN
Market Price
$0.67
Market Cap
$85.54M
P/E Ratio
N/A
Revenue (FY 2025)
↓-10.0% YoY
$300.79M
3-Yr CAGR: -6.3%
Net Income
N/A
Net Margin: N/A
Free Cash Flow
↑141.8% YoY
$37.18M
FCF Yield: 43.47%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity
Efficiency
N/A
ROA: N/A
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (SKIN)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2019 | $166.6M | — | $106.5M | — | — | — | — | $1.7M | — | — |
| FY 2020 | $119.1M | -28.5% | $67.2M | — | — | — | — | $-12.4M | — | — |
| FY 2021 | $260.1M | +118.4% | $181.8M | — | — | — | — | $-28.4M | $-44.0M | — |
| FY 2022 | $365.9M | +40.7% | $250.3M | — | — | — | — | $-106.6M | $-124.0M | -182.0% |
| FY 2023 | $398.0M | +8.8% | $155.1M | — | — | — | — | $21.8M | $17.9M | +114.5% |
| FY 2024 | $334.3M | -16.0% | $182.3M | — | — | — | — | $16.1M | $15.4M | -14.2% |
| FY 2025 | $300.8M | -10.0% | $196.4M | — | — | — | — | $37.5M | $37.2M | +141.8% |
Valuation
Market Price
$0.67
Market Cap
$85.54M
Enterprise Value
N/A
P/E Ratio
N/A
P/B Ratio
1.42
FCF Yield
43.47%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
65.28%
Operating Margin
N/A
Net Margin
N/A
Return on Equity (ROE)
N/A
Return on Assets (ROA)
N/A
Asset Turnover
0.60x
Revenue 3-Yr CAGR
-6.32%
Financial Health & Liquidity
Current Ratio
1.05
Cash Ratio
N/A
Debt / Equity
3.938
Debt / Assets
0.481
Cash & Equivalents
N/A
Total Debt
$240.43M
Book Value / Share
$0.47
Cash Flow Efficiency
Operating Cash Flow
$37.48M
Capital Expenditures (CapEx)
$303.00K
Free Cash Flow
$37.18M
OCF / Revenue
12.46%
FCF / Revenue
12.36%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
N/A
EPS (Basic)
N/A
Dividends / Share
N/A
Book Value / Share
$0.47
EPS YoY Growth
N/A
Balance Sheet (FY 2025)
Total Assets
$499.80M
Total Liabilities
$499.80M
Stockholders' Equity
$61.06M
Current Assets
$5.39M
Current Liabilities
$5.13M